Systemic in vivo antitumor activity of interleukin-12 against both transplantable and primary tumor

被引:14
作者
Nishimura, T
Watanabe, K
Lee, U
Yahata, T
Ando, K
Kimura, M
Hiroyama, Y
Kobayashi, M
Herrmann, SH
Habu, S
机构
[1] TOKAI UNIV,SCH MED,DEPT INFECT DIS,ISEHARA,KANAGAWA 25911,JAPAN
[2] TOKAI UNIV,SCH MED,DEPT MOLEC LIFE SCI,ISEHARA,KANAGAWA 25911,JAPAN
[3] DNARD INC,KAWASAKI,KANAGAWA 216,JAPAN
[4] GENET INST INC,CAMBRIDGE,MA 02140
关键词
interleukin-12; tumor immunotherapy; primary tumor; mouse;
D O I
10.1016/0165-2478(95)02448-4
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:149 / 152
页数:4
相关论文
共 15 条
[11]   INTERLEUKIN-12 AUGMENTS THE GENERATION OF AUTOLOGOUS TUMOR-REACTIVE CD8(+) CYTOTOXIC T-LYMPHOCYTES FROM TUMOR-INFILTRATING LYMPHOCYTES [J].
KUGE, S ;
WATANABE, K ;
MAKINO, K ;
TOKUDA, Y ;
MITOMI, T ;
KAWAMURA, N ;
HABU, S ;
NISHIMURA, T .
JAPANESE JOURNAL OF CANCER RESEARCH, 1995, 86 (02) :135-139
[12]  
NASTALA CL, 1994, J IMMUNOL, V153, P1697
[13]  
NISHIMURA T, 1986, CANCER IMMUNOL IMMUN, V21, P12
[14]   INFLUENCE OF INTERLEUKIN-12 ON P53 PEPTIDE VACCINATION AGAINST ESTABLISHED METH-A SARCOMA [J].
NOGUCHI, Y ;
RICHARDS, EC ;
CHEN, YT ;
OLD, LJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (06) :2219-2223
[15]   PERFORIN IS EXPRESSED IN CTL POPULATIONS GENERATED INVIVO [J].
TAKEUCHI, Y ;
NISHIMURA, T ;
GAO, XH ;
WATANABE, K ;
AKATSUKA, A ;
SHINKAI, Y ;
OKUMURA, K ;
HABU, S .
IMMUNOLOGY LETTERS, 1992, 31 (02) :183-187